CDSCO re-constitutes its Internal Complaint Committee on Sexual Harassment
The CDSCO has re-constituted and notified the members of the Internal Complaint Committee that will deal with the complaints of working women on sexual harassment at the workplace.
CDSCO requests that Samples of Cough Syrup not be submitted to CDTL Mumbai and IPC Ghaziabad Labs
CDSCO has instructed all manufacturers and exporters to refrain from submitting any samples to CDTL Mumbai and IPC Ghaziabad Labs until it completes analysis and release of pending reports.
Gambia mandates Pre-shipment Inspection and Testing for Indian Pharmaceutical Products
These requirements seek to address issues of substandard and counterfeit medicines entering into Gambia from India and will be effective from 1st July, 2023.
CDSCO requests that Samples of Cough Syrup not be submitted to CDTL Mumbai Lab
CDSCO has observed that based on data for 21st June, 2023, CDTL Mumbai Lab has 93 samples of cough syrup under testing.. Hence it has instructed all manufacturers and exporters in the state of Maharashtra to refrain from submitting any samples to CDTL Mumbai Lab until it completes analysis and release of pending reports.
CDSCO publishes List of Drugs, Medical Devices and Cosmetics declared as Not of Standard Quality/Spurious for May 2023
This list includes a total of 28 drugs, medical devices and cosmetics that are identified as being deficient. Out of these 28 samples, 27 were declared as not of standard quality and 1 was declared spurious.
CDSCO to update Number of Batches of Cough Syrups at Different Labs
This measure is intended to foster work distribution among the labs and release of test reports in a timely manner. Hence, drug manufacturers/ exporters can view this information and submit their samples to laboratories having fewer samples as compared to other labs.
